Jump to content

Dermal equivalent

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Citation bot (talk | contribs) at 13:31, 4 August 2018 (Alter: . Add: year, pages, issue, volume, journal, title, author pars. 1-4. You can use this bot yourself. Report bugs here.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

The dermal equivalent is an in vitro model of the dermal layer of skin. It is constructed by seeding dermal fibroblasts into a collagen gel. This gel may then be allowed to contract as a model of wound contraction. This collagen gel contraction assay may be used to screen for treatments which promote or inhibit contraction and thus affect the development of a scar. Other cell types may be incorporated into the dermal equivalent to increase the complexity of the model. For example, keratinocytes may be seeded on the surface to create a skin equivalent, or macrophages may be incorporated to model the inflammatory phase of wound healing.[1]

References

  1. ^ Newton, P. M; Watson, J. A; Wolowacz, R. G; Wood, E. J (2004). "Macrophages Restrain Contraction of an in Vitro Wound Healing Model". Inflammation. 28 (4): 207–214. doi:10.1023/B:IFLA.0000049045.41784.59.